EURONEXT:SIGHT
GenSight Biologics S.A.
- Stock
locale
France
market
STOCKSindustry
Biotechnologywebsite
www.gensight-biologics.comipo date
Jul 13, 2016
GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product can...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus